Prodesse
Signal active
Organization
Contact Information
Overview
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications. Prodesse sells three FDA 510(k) cleared products in the United States, and two additional CE-marked products in Europe. The company's products can be used in conjunction with various nucleic acid extraction and real-time PCR (polymerase chain reaction) platforms, including Cepheid's SmartCycler(®) II System.
About
Industries
Biotechnology, Medical
Founded
1993
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Prodesse headquartered in United States, North America, operates in the Biotechnology, Medical sector. The company focuses on Biotechnology and has secured $12.0M in funding across 8 round(s). With a team of 1-10 employees, Prodesse is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Prodesse, raised $1.5M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$1.5M
Details
1
Prodesse has raised a total of $1.5M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2002 | Seed | 1.5M |
Investors
Prodesse is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jeff Rusinow | - | FUNDING ROUND - Jeff Rusinow | 1.5M |
| Silicon Pastures | - | FUNDING ROUND - Silicon Pastures | 1.5M |
| Prodesse | - | FUNDING ROUND - Prodesse | 1.5M |
| Wisconsin Investment Partners | - | FUNDING ROUND - Wisconsin Investment Partners | 1.5M |
Recent Activity
There is no recent news or activity for this profile.